BSc (Hons) (First Class, Brisbane, Australia, 1990), PhD (Aberdeen, 1997)
Manager, Centre for Genome Enabled Biology & Medicine
- About
-
- Email Address
- e.collie-duguid@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437958
- Office Address
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
I was awarded a first class BSc (Hons) degree in molecular biology from the University of Queensland, Brisbane, Australia in 1990. My time as a research assistant at the Centre for Molecular Biology and Biotechnology (currently The Institute of Molecular Bioscience), University of Queensland, was followed by a period of international travel, culminating in a move to Aberdeen in 1993 to complete my PhD in molecular and cellular biology at the Rowett Research Institute. I joined the University of Aberdeen in 1996 as a post-doctoral scientist studying tumour biology and mechanisms of chemoresistance under Dr Howard Macleod and Professor Jim Cassidy. In 2014, I was appointed to establish and lead development of the Centre for Genome Enabled Biology and Medicine (CGEBM), a centre for genomics and bioinformatics at the University of Aberdeen. I continue to lead CGEBM and in 2024 I was appointed as Strategic lead for the Institute of Medical Sciences Facilities Centre at the University of Aberdeen to head the strategic direction, innovation and operational evolution of cytometry, genomics, histology, microscopy and proteomics. I have a research focus in tumour biology with a particular interest in breast cancer.
The technology hubs within the Institute of Medical Sciences Facilities Centre provide specialist expertise, infrastructure, training and a hub for methodological innovation, collaborative and interdisciplinary research design and information exchange, and bespoke research goal-oriented support in bioinformatics, cytometry, genomics, histology, microscopy and proteomics. This incorporates integrated application across technological fields in an era of multi-omics and sophisticated cellular and molecular resolution to drive understanding across diverse programmes of applied translational, clinical, biomedical and biological research at the University of Aberdeen and beyond and addressing global challenges in human health and disease, agriculture and the environment.
Memberships and Affiliations
- Internal Memberships
-
University of Aberdeen
Aberdeen Grants Academy: Institutional Capital Equipment panel member
Research Facilities Working Group member
Research and Innovation Committee member, Institute of Medical Sciences
- External Memberships
-
2024 - Breast Cancer Now Prevention and Cure Grants Committee member.
2009 - 2014 Scientific Member, Experimental and Translational Medicine Research Committee, Chief Scientist Office.
2005 - 2009 Scientific Member, Biomedical and Therapeutics Research Committee, Chief Scientist Office.
Professional memberships
Genetics Society
British Association of Cancer Research
European Association of Cancer Research
- Research
-
Research Overview
Dr Collie-Duguid's research interest is to understand the molecular and cellular mechanisms controlling tumorigenesis, survival of cancer patients and chemoresistance in solid tumours, with a particular focus on breast cancers. Biomarker discovery for prediction of clinical outcomes, including response to therapy; and novel drug target identification for drug development are key elements of her translational research programme. Dr Collie-Duguid has an interest in using genomic tools to understand human disease and important biological processes.
- Teaching
-
Teaching Responsibilities
I am course co-ordinator and teach MB5522 Advanced Bioinformatics and Genome Sequencing. I teach level 5 MB5021 Bioinformatics, MB5029 Toxicology and MT5515 Basic Research Methods; level 4 PA4303 Current Topics in Pharmacological research; level 3 PA3802 Mechanisms of Disease and Principles of Chemotherapy and provide research project supervision to level 5 MSc students and BSc Honours students in the fields of cancer biology and genomics.
- Publications
-
Page 1 of 1 Results 1 to 66 of 66
Reproducible profiling of the gut microbiota using surplus clinical Faecal Immunochemical Test (FIT) samples
Microbial GenomicsContributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1099/mgen.0.001740
- [ONLINE] View publication in Scopus
Identification of lens-regulated genes driving anterior eye development
Developmental Biology, vol. 520, pp. 91-107Contributions to Journals: ArticlesDietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity
Microbiome, vol. 12, no. 1, 89Contributions to Journals: ArticlesVenomous gland transcriptome and venom proteomic analysis of the scorpion Androctonus amoreuxi reveal new peptides with anti-SARS-CoV-2 activity. Peptides
Peptides, vol. 173, 171139Contributions to Journals: ArticlesHomemade Nucleic Acid Preservation Buffer Proves Effective in Preserving the Equine Faecal Microbiota over Time at Ambient Temperatures
Animals, vol. 13, no. 19, 3107Contributions to Journals: ArticlesEffect of feed concentration and residence time on anaerobic fermentation in CSTR and SBR to produce short-chain organic acids
Journal of Environmental Chemical Engineering, vol. 11, no. 5, 110461Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.jece.2023.110461
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/7538ae7f-d90c-4aca-8af2-5cffa25a50da/download
- [ONLINE] View publication in Scopus
Effect of sampling and storage conditions upon equine fecal microbial community
Chapters in Books, Reports and Conference Proceedings: Conference Proceedings- [ONLINE] DOI: https://doi.org/10.1016/j.jevs.2023.104308
Taxonomy of fibroblasts and progenitors in the synovial joint at single-cell resolution
Annals of the Rheumatic Diseases, vol. 82, no. 3, pp. 428-437Contributions to Journals: Articlesβ-glucan is a major growth substrate for human gut bacteria related to Coprococcus eutactus
Environmental Microbiology, vol. 22, no. 6, pp. 2150-2164Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/1462-2920.14977
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/703c92c1-5f5c-46fc-908d-6d4a28807891/download
- [ONLINE] View publication in Scopus
VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
Journal of Cell Science, vol. 132, jcs225946Contributions to Journals: ArticlesVgll3 interacts with Yap/Taz-Tead1-4-dependent gene expression in skeletal muscle
2019 Spring Padua Muscle Days, pp. 53-53Contributions to Journals: AbstractsFormate cross-feeding and cooperative metabolic interactions revealed by transcriptomics in co-cultures of acetogenic and amylolytic human colonic bacteria
Environmental Microbiology, vol. 21, no. 1, pp. 259-271Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/1462-2920.14454
- [OPEN ACCESS] https://aura.abdn.ac.uk/bitstreams/9be83065-a6da-49d0-9745-3e1b55f99183/download
- [ONLINE] View publication in Mendeley
Jaundice in newborns could be an evolutionary safeguard against death from sepsis
The ConversationContributions to Specialist Publications: ArticlesAdaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin
Scientific Reports, vol. 8, pp. 1-10Contributions to Journals: ArticlesCommon and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function
Stem Cells, vol. 35, no. 8, pp. 1958-1972Contributions to Journals: ArticlesFine mapping of genes determining extrafusal fiber properties in murine soleus muscle
Physiological Genomics, vol. 49, no. 3, pp. 141-150Contributions to Journals: ArticlesRegulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer
BMC Cancer, vol. 15, 762Contributions to Journals: ArticlesTumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas
British Journal of Cancer, vol. 110, no. 6, pp. 1525-1534Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/bjc.2014.45
Influence of resistance to 5-fluorouracil and tomudex on [18F]-FDG incorporation, glucose transport and hexokinase activity
International Journal of Oncology, vol. 41, no. 1, pp. 378-382Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.3892/ijo.2012.1439
SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy
Breast Cancer Research and Treatment, vol. 132, no. 3, pp. 807-818Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s10549-011-1625-9
Optimized response prediction in esophagogastric junction adenocarcinomas (EGJAc) with combination of molecular biomarkers and FDG-PET
Journal of Clinical Oncology, vol. 30, no. Suppl. 4, 1Contributions to Journals: AbstractsMAGEA tumour antigens mediate platinum cytotoxicity in NSCLC
European Journal of Cancer, vol. 8, no. 7, pp. 99-100Contributions to Journals: AbstractsSerpinB3, a biomarker of taxane benefit in breast cancer
1st British Breast Cancer Research Conference, pp. 13Contributions to Journals: AbstractsAberdeen Microarray and PET in Optimising Oesophagogastric Cancer Response-1 (AMPETOOR-1). Preliminary Results: Preliminary Results
Annals of Oncology, vol. 21, pp. 43Contributions to Journals: ArticlesAPRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling
BMC Cancer, vol. 9, pp. 434Contributions to Journals: ArticlesBalancing Inflammatory, Lipid, and Xenobiotic Signaling Pathways by VSL#3, a Biotherapeutic Agent, in the Treatment of Inflammatory Bowel Disease
Inflammatory Bowel Diseases, vol. 15, no. 11, pp. 1721-1736Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/ibd.20999
Gene expression analysis of human fetal ovarian primordial follicle formation
Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 4, pp. 1427-1435Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1210/jc.2008-2619
Growth hormone in vascular pathology: Neovascularisation and expression of receptors is associated with cellular proliferation
Anticancer Research, vol. 28, no. 2B, pp. 1439Contributions to Journals: ArticlesDecreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro
Nuclear Medicine and Biology, vol. 34, no. 8, pp. 955-960Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.nucmedbio.2007.07.007
Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks
Cancer Chemotherapy and Pharmacology, vol. 59, no. 6, pp. 839-845Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00280-006-0384-5
Cancer Therapy Prognosis and Target
Patents: PatentsPregnane X Receptor Activators Inhibit Human Hepatic Stellate Cell Trans-Differentiation in Vitro
Gastroenterology, vol. 131, no. 1, pp. 194-209Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1053/j.gastro.2006.04.012
Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer
Journal of Clinical Oncology, vol. 24, no. 11, pp. 1729-1744Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1200/JCO.2005.03.3399
The Rectal Adenocarcinoma Transcriptome Reveals a Novel Prognostic Biomarker and Candidate Novel Targets for Neoadjuvant Therapy (Aberdeen Microarray in Rectal Cancer Study-1; AMRECS-1)
Colorectal Disease, vol. 8, no. S2Contributions to Journals: ArticlesGene expression profiling of clinical response in rectal adenocarcinomas reveals novel predictive biomarkers and therapeutic targets.
Contributions to Conferences: AbstractsGlobal gene expression profiling of clinical response to radiotherapy and chemoradiotherapy in rectal adenocarcinoma reveals distinct and common molecular mechanisms of action.
Contributions to Conferences: AbstractsIdentification of the lysosomal programmed cell death (PCD) pathway as a critical determinant of clinical response in Non-Small Cell Lung Cancer (NSCLC).
Lung Cancer, vol. 49, no. S141-142Contributions to Journals: ArticlesPutative Novel Mechanisms Of Tomudex Resistance And Insight Into TS-Independent 5-Flurouracil Resistance Networks.
Contributions to Conferences: AbstractsRectal adenocarcinoma transcriptome profiles reveal distinct molecular effects of radiotherapy and chemoradiotherapy (Aberdeen Microarray in Rectal Cancer Study-1; AMRECS-1).
Contributions to Conferences: AbstractsRole of CD200 in tolerance induction: gene expression profiling of lymphoid tissues in response to intranasal antigen.
Immunology, vol. 116, no. 13Contributions to Journals: ArticlesMechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells
Cancer Research, vol. 64, pp. 8167-8176Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1158/0008-5472.CAN-04-0970
Global profiling of molecular mechanisms of 5-fluorouracil, resistance in human cancer cells.
British Journal of Cancer, vol. 91, no. S1Contributions to Journals: ArticlesMolecular mechanisms of platinum (Pt) based chemotherapy in non-small cell lung cancer patients (NSCLC) using microarrays
British Journal of Cancer, vol. 91, no. Supplement 1, pp. S14-S14Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1038/sj.bjc.6601930
A molecular profile that predicts response to platinum based chemotherapy in non-small cell lung cancer (NSCLC) patients
British Cancer Research Meeting 2004, pp. S14-S14Contributions to Journals: AbstractsGene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application
Clinical Cancer Research, vol. 10, no. 10, pp. 3237-3248Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1158/1078-0432.CCR-03-0503
Global analysis of molecular genetic mechanisms in anti-cancer drug chemoresistance
Contributions to Conferences: AbstractsMicroarrays identify prognostic profiles in colon cancer patients and potential mechanisms of 5FU chemoresistance
British Journal of Cancer, vol. 91, pp. S12-S12Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/sj.bjc.6601929
Molecular profiling identifies novel cell death pathways involved in Non-Small Cell Lung Cancer (NSCLC) chemoresistance and allows prediction of response.
Contributions to Conferences: AbstractsMolecular profiling of response to platinum based therapy in non-small cell lung cancer (NSCLC) patients.
Journal of Clinical Oncology, vol. 22, no. 14, pp. 153S-2104Contributions to Journals: ArticlesMolecular signatures for prognosis prediction in colon cancer patients
Contributions to Conferences: AbstractsGene expression profiling of apoptosis and cell cycle control in Dukes’ C colon tumours
British Journal of Cancer, vol. 88, no. S1, pp. S48Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/sj.bjc.6601056
Molecular mechanisms of cytotoxicity and pathogenesis in non-small cell lung cancer (NSCLC) using gene expression profiling.
British Journal of Cancer, vol. 88, no. S1Contributions to Journals: ArticlesCerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines
FEBS Letters, vol. 531, no. 3, pp. 415-420Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0014-5793(02)03575-5
Pyrimidine Metabolism and G1/S transition in colon tumours.
British Journal of Cancer, vol. 86, no. S1Contributions to Journals: ArticlesThymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer
International Journal of Cancer, vol. 94, no. 2, pp. 297-301Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/ijc.1462
A clinician's guide to the polmerase chain reaction
UroOncology, vol. 1, pp. 103-112Contributions to Journals: Literature ReviewsCloning and initial characterization of the human DPYD gene promoter
Biochemical and Biophysical Research Communications, vol. 271, pp. 28-35Contributions to Journals: ArticlesEstimation of dihydropyrimidine dehydrogenase activity: Does it have a role in cancer therapy?
Annals of Oncology, vol. 11, pp. 255-257Contributions to Journals: EditorialsKnown variant DPYD alleles do not explain DPD deficiency in cancer patients
Pharmacogenetics, vol. 10, pp. 217-223Contributions to Journals: ArticlesTherapeutic opportunities from tumour biology in metastatic colon cancer
European Journal of Cancer, vol. 36, no. 13, pp. 1706-1712Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/S0959-8049(00)00150-7
Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations
Genomics, vol. 58, no. 3, pp. 310-312Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1006/geno.1999.5833
Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals
Pharmacogenetics, vol. 9, pp. 773-776Contributions to Journals: ArticlesThe frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
Pharmacogenetics, vol. 9, pp. 37-42Contributions to Journals: ArticlesThiopurine methyltransferase alleles in British and Ghanaian populations
Human Molecular Genetics, vol. 8, pp. 367-370Contributions to Journals: ArticlesThiopurine Methyltransferase Genotype Predicts Therapy-Limiting Severe Toxicity from Azathioprine
Annals of Internal Medicine, vol. 129, no. 9, pp. 716-718Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.7326/0003-4819-129-9-199811010-0000
Nomenclature for human DPYD alleles
Pharmacogenetics, vol. 8, pp. 455-459Contributions to Journals: Articles